118 related articles for article (PubMed ID: 34057866)
21. The Biology of β-D-mannuronic acid (M2000) on Human Dendritic Cell Based on MicroRNA-155 and MicroRNA-221.
Tabrizian N; Fard NA; Farazmand A; Eftekhari R; Zavareh FT; Mirshafiey A
Curr Drug Discov Technol; 2017; 14(1):53-58. PubMed ID: 27890012
[TBL] [Abstract][Full Text] [Related]
22. Effects of β-d-mannuronic acid, as a novel non-steroidal anti-inflammatory medication within immunosuppressive properties, on
Barati A; Jamshidi AR; Ahmadi H; Aghazadeh Z; Mirshafiey A
Drug Des Devel Ther; 2017; 11():1027-1033. PubMed ID: 28408801
[TBL] [Abstract][Full Text] [Related]
23. Effect of β-D-Mannuronic Acid (M2000) on Oxidative Stress Enzymes' Gene Using Healthy Donor Peripheral Blood Mononuclear Cells for Evaluating the Anti-Aging Property.
Taeb M; Jafarzadeh A; Mortazavi-Jahromi SS; Zainodini N; Mirzaei MR; Jafarnezhad-Ansariha F; Aghazadeh Z; Mirshafiey A
Curr Drug Discov Technol; 2019; 16(3):265-271. PubMed ID: 29766814
[TBL] [Abstract][Full Text] [Related]
24. The Potent Inhibitory Effect of β-D-Mannuronic Acid (M2000) as a Novel NSAID with Immunosuppressive Property on Anti-Cyclic Citrullinated Peptide Antibodies, Rheumatoid Factor and Anti-dsDNA Antibodies in Patients with Rheumatoid Arthritis.
Ahmadi H; Jamshidi AR; Mahmoudi M; Cuzzocrea S; Fattahi MJ; Barati A; Rehm BHA; Matsuo H; Mirshafiey A
Curr Drug Discov Technol; 2017; 14(3):206-214. PubMed ID: 28325148
[TBL] [Abstract][Full Text] [Related]
25. Therapeutic approach by a novel designed anti-inflammatory drug, M2000, in experimental immune complex glomerulonephritis.
Mirshafiey A; Rehm B; Sotoude M; Razavi A; Abhari RS; Borzooy Z
Immunopharmacol Immunotoxicol; 2007; 29(1):49-61. PubMed ID: 17464766
[TBL] [Abstract][Full Text] [Related]
26. Anti-aging effects of M2000 (β-D-mannuronic acid) as a novel immunosuppressive drug on the enzymatic and non-enzymatic oxidative stress parameters in an experimental model.
Hosseini S; Abdollahi M; Azizi G; Fattahi MJ; Rastkari N; Zavareh FT; Aghazadeh Z; Mirshafiey A
J Basic Clin Physiol Pharmacol; 2017 May; 28(3):249-255. PubMed ID: 28207414
[TBL] [Abstract][Full Text] [Related]
27. The Safety Property of β-D-Mannuronic Acid (M2000) as a Novel Immunosuppressive Agent on Differentiation, Maturation and Function of Human Dendritic Cells.
Fard NA; Tabrizian N; Mirzaei R; Motamed N; Zavareh FT; Mirshafiey A
Curr Drug Discov Technol; 2016; 13(3):164-169. PubMed ID: 27335103
[TBL] [Abstract][Full Text] [Related]
28. The Anti-Migraine Effects of M2000 (β-D-Mannuronic Acid) on a Patient with Rheumatoid Arthritis: Case Report.
Vojdanian M; Ahmadi H; Jamshidi AR; Mahmoudi M; Gharibdoost F; Barati A; Mirshafiey A
Curr Clin Pharmacol; 2017; 12(2):127-130. PubMed ID: 28578645
[TBL] [Abstract][Full Text] [Related]
29. Tau and amyloid beta differentially affect the innate immune genes expression in Drosophila models of Alzheimer's disease and β- D Mannuronic acid (M2000) modulates the dysregulation.
Barati A; Masoudi R; Yousefi R; Monsefi M; Mirshafiey A
Gene; 2022 Jan; 808():145972. PubMed ID: 34600048
[TBL] [Abstract][Full Text] [Related]
30. An in vitro assessment for evaluating the efficiency of β-d-mannuronic acid (M2000) in myelodysplastic syndrome.
Bakhtiari T; Ghaderi A; Safaee Nodehi SR; Aghazadeh Z; Tofighi Zavareh F; Jafarnezhad-Ansariha F; Barati A; Mirshafiey A
J Cell Physiol; 2019 Aug; 234(8):12971-12977. PubMed ID: 30537258
[TBL] [Abstract][Full Text] [Related]
31. Anti-diabetic effect of
Mortazavi-Jahromi SS; Alizadeh S; Javanbakht MH; Mirshafiey A
Arch Physiol Biochem; 2019 Dec; 125(5):435-440. PubMed ID: 29882437
[TBL] [Abstract][Full Text] [Related]
32. Modification of Sexual Hormones in Rheumatoid Arthritis Patients by M2000 (β-D-mannuronic Acid) as a Novel NSAID with Immunosuppressive Property.
Jahanbakhshi M; Babaloo Z; Mortazavi-Jahromi SS; Shokri MM; Ahmadi H; Mirshafiey A
Endocr Metab Immune Disord Drug Targets; 2018; 18(5):530-536. PubMed ID: 29667557
[TBL] [Abstract][Full Text] [Related]
33. Chemopreventive effect of M2000, a new anti-inflammatory agent.
Mirshafiey A; Khorramizadeh MR; Saadat F; Rehm BH
Med Sci Monit; 2004 Oct; 10(10):PI105-9. PubMed ID: 15448610
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of G2013 (α-L-guluronic acid) efficacy on PC-3 cells through inhibiting the expression of inflammatory factors.
Bagherian Z; Mirshafiey A; Mohsenzadegan M; Farajollahi MM
Clin Exp Pharmacol Physiol; 2022 Feb; 49(2):254-263. PubMed ID: 34699087
[TBL] [Abstract][Full Text] [Related]
35. Cardioprotective effect of β-d-mannuronic acid (M2000) as a novel NSAID on gene expression of oxLDL scavenger receptors in the experimental diabetic model.
Mortazavi-Jahromi SS; Alizadeh S; Javanbakht MH; Mirshafiey A
Immunopharmacol Immunotoxicol; 2018 Aug; 40(4):284-289. PubMed ID: 29619884
[TBL] [Abstract][Full Text] [Related]
36. The Situation of Chemokine Ligands and Receptors Gene Expression, Following the Oral Administration of Drug Mannuronic Acid in Rheumatoid Arthritis Patients.
Aslani M; Ahmadzadeh A; Rezaieyazdi Z; Mortazavi-Jahromi SS; Barati A; Hosseini M; Mirshafiey A
Recent Pat Inflamm Allergy Drug Discov; 2020; 14(1):69-77. PubMed ID: 31729947
[TBL] [Abstract][Full Text] [Related]
37. β-D-Mannuronic Acid (M2000) as a Landmark in Pharmacology.
Gaafar NAG; Razavi A; Mirshafiey A
Curr Drug Discov Technol; 2021; 18(1):47-57. PubMed ID: 31880246
[TBL] [Abstract][Full Text] [Related]
38. A controlled, randomized phase II clinical trial for efficacy and safety evaluation of mannuronic acid in secondary progressive form of multiple sclerosis.
Najafi S; Moghadam NB; Saadat P; Noorbakhsh SM; Mohammadi AV; Manouchehrinia A; Hosseini M; Matsuo H; Mirshafiey A
Int J Neurosci; 2022 Apr; 132(4):403-412. PubMed ID: 32878514
[TBL] [Abstract][Full Text] [Related]
39. Immunotherapeutic Effects of β-D Mannuronic Acid on IL-4, GATA3, IL-17 and RORC Gene Expression in the PBMC of Patients with Inflammatory Bowel Diseases.
Alhassan Mohammed H; Saboor-Yaraghi AA; Vahedi H; Panahi G; Hemmasi G; Yekaninejad MS; Mirshafiey A
Iran J Allergy Asthma Immunol; 2018 Aug; 17(4):308-317. PubMed ID: 30537794
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of the Effect of Mannuronic Acid as a Novel NSAID With Immunosuppressive Properties on Expression of SOCS1, SOCS3, SHIP1, and TRAF6 Genes and Serum Levels of IL-6 and TNF-α in Patients With Multiple Sclerosis.
Najafi S; Saadat P; Beladi Moghadam N; Manoucherinia A; Aghazadeh Z; Vali Mohammadi A; Pashaiefar H; Hosseini M; Mirshafiey A
J Clin Pharmacol; 2021 Oct; 61(10):1303-1310. PubMed ID: 33908653
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
